Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
1.3 Instruments HPLC was performed on an ekspert ™ ultraLC 100 system (AB-Sciex; Foster City, CA, USA) with a cooling auto-sampler and a binary solvent delivery pump. The tandem triple-quadrupole mass spectrometer was from API Qtrap 5500 (Applied Biosystems-Sciex; Foster City, CA, USA). Data were acquired and processed using Analyst 1.6.1 software.
HPLC conditions
An Acquity UPLC ™ HSST3 column (100 ×2.1 mm, 1.8 μm; Waters Corp., Milford, MA, USA) was employed for the separation at 40°C. The mobile phase consisted of Solvent A (10 mM ammonium acetate containing 0.1% formic acid) and Solvent B (acetonitrile). The 9-min gradient was as follows: from 0 to 0.5 min, the percentage of eluent B was maintained at 20%; from 0.5 to 5 min, the percentage of eluent B linearly increased from 20% to 90%, and was maintained at 90% for 0.5 min, then returned to 20% in 0.1 min and was maintained at 20% for 3.5 min. The flow rate was set at 0.3 mL/min. The auto-sampler was conditioned at 4°C in this method.
Mass spectrometry.
A tandem triple-quadrupole mass spectrometry (Applied Biosystems-Sciex API Qtrap5500; Foster City, CA, USA) was operated in negative electrospray ionization (ESI-) mode. The multiple reaction monitoring mode was selected for quantification of the analytes, for which the precursors to production ion transitions were as follows: niclosamide 327→172.9 and naproxen 228.9→185.1. The ion source temperature was maintained at 550°C and the ionspray voltage was -4.5 kV. Analyst ® 1.6.1 software (Applied Biosystems-Sciex; Foster City, CA, USA) was used.
Preparation of standards and quality control samples
Standard master stock solutions of niclosamide (1 mg/mL) and naproxen (IS) (1 mg/mL) were obtained by dissolving an appropriate amount of niclosamide and internal standard (IS) in acetonitrile. These stock solutions were serially diluted and added to Sprague-Dawley (SD) rat plasma (ratio 1:9), to produce final concentrations of 1, 5, 10, 50, 100, 250, 500, and 1000 ng/mL for niclosamide. Quality control samples were similarly prepared using a stock solution. The lower limit of quantification and low (L), medium (M), and high (H) quality controls were prepared in plasma at concentrations of 1, 3, 450, and 900 ng/mL, respectively. The IS stock solution containing naproxen (1 mg/mL) was diluted with acetonitrile to prepare a final concentration of 1,000 ng/mL.
Sample extraction
SD rat plasma (20 μL) was mixed with 200 μL of acetonitrile containing 1,000 ng/mL of naproxen as IS. The mixture was vortexed for 30 s and then centrifuged at 6,000g for 5 min in an Eppendorf centrifuge at 4°C. An aliquot of 5 μL of the supernatant was injected into the HPLC-MS/MS system for analysis.
